03.01.2013 Views

scientific program • symposia - American Society for Reproductive ...

scientific program • symposia - American Society for Reproductive ...

scientific program • symposia - American Society for Reproductive ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

SCIENTIFIC PROGRAM <strong>•</strong> INTERACTIVE SESSIONS<br />

Wednesday, October 19, 2011 1:15 pm – 2:15 pm<br />

Interactive Session<br />

SCIENTIFIC OPPORTUNITIES IN GENERATING GAMETES FROM<br />

INFERTILITY PATIENTS’ STEM CELLS<br />

Presented by the Regenerative Medicine and Stem Cell Special Interest<br />

Group<br />

Gerald P. Schatten, Ph.D. (Chair)<br />

University of Pittsburgh School of Medicine<br />

Gianpiero D. Palermo, M.D., Ph.D.<br />

Cornell University<br />

Needs Assessment and Description<br />

Significant progress has been made in making gametes of<br />

varying quality in model murine systems from pluripotent<br />

stem cells in vitro. These strategies hold promise <strong>for</strong> designing<br />

novel contraceptives, treating infertility and restoring<br />

fertility in children who survive cancer. While most of<br />

these breakthroughs are highly promising from research<br />

perspectives and typically are successful using inbred<br />

strains of certain murine models, the gap between the<br />

announcement of a breakthrough in the lay publications<br />

and the actual successful translation to the clinical setting<br />

as a responsible and reliable therapy can take decades.<br />

Consequently, there are ongoing and urgent needs <strong>for</strong> the<br />

ASRM community to in<strong>for</strong>m colleagues about the <strong>scientific</strong><br />

status of stem cells and regenerative medicine, and to keep<br />

them updated on the progress of the long process <strong>for</strong> safely<br />

translating them to the ART <strong>for</strong> routine clinical practice.<br />

MALE-TO-FEMALE TRANSGENDER SURGERY: TECHNIQUES,<br />

RESULTS AND POSTOPERATIVE SEXUALITY<br />

Joint Session presented by the <strong>Society</strong> of <strong>Reproductive</strong> Surgeons and the<br />

Sexuality Special Interest Group<br />

Stanton C. Honig, M.D. (Chair)<br />

University of Connecticut School of Medicine<br />

Jared C. Robins, M.D.<br />

The Warren Alpert Medical School of Brown University<br />

Christine McGinn, M.D.<br />

Papillion Center, New Hope, Pennsylvania<br />

Needs Assessment and Description<br />

The reproductive endocrinologist, urologist, mental health<br />

professional, nurse or other health care provider may be<br />

faced with the evaluation and treatment of the transgender<br />

patient. The evaluation of the transgender patient <strong>for</strong><br />

surgery is complex and generally requires that the patient<br />

meet the World Professional Association <strong>for</strong> Transgender<br />

Health (WPATH) Standards of Care <strong>for</strong> Gender Identity<br />

Disorders <strong>for</strong> consideration <strong>for</strong> surgery. This includes real<br />

life experience <strong>for</strong> 1 year, 1 year of hormone replacement<br />

therapy and documentation of stable mental health by two<br />

health care professionals.<br />

The surgical approach <strong>for</strong> male-to-female treatment<br />

is complex and usually requires orchiectomy, partial<br />

penectomy and creation of a neoclitoris, neourethra,<br />

neovagina (different methods will be discussed) and<br />

creation of an external genital introitus, usually with scrotal<br />

skin. Postoperative care will be discussed as well as the<br />

importance of the creation of reasonable postoperative<br />

expectations of sexuality.<br />

Room 224 C/D<br />

94<br />

Learning Objectives<br />

At the conclusion of this session, participants should be able<br />

to:<br />

1. Identify evidence-based developments <strong>for</strong> the use of<br />

stem cells in the treatment of disorders related to infertility.<br />

2. Critically appraise the state of the <strong>scientific</strong> knowledge<br />

and the steps necessary to translate this in<strong>for</strong>mation<br />

regarding the generation of sperm from pluripotent stem<br />

cells to the ART clinic.<br />

ACGME COMPETENCY<br />

Medical Knowledge<br />

TEST QUESTION:<br />

A male infertility patient has been successfully treated by<br />

the transfer of spermatogenic stem cells into his previously<br />

aspermic testes. Which one of the following statements is<br />

true, given the state of the field in 2011?<br />

A. The patient is a childhood survivor of cancer, which<br />

rendered him infertile, but the thawing of his previously<br />

frozen spermatogenic cells transferred after puberty,<br />

restored his fertility.<br />

B. The patient is a mouse.<br />

C. The patient is a man who suffered previously from<br />

idiopathic male infertility.<br />

D. The patient is a man with Sertoli cell only syndrome.<br />

Wednesday, October 19, 2011 1:15 pm – 2:15 pm<br />

Interactive Session<br />

Room 222<br />

Learning Objectives<br />

At the conclusion of this session, participants should be able<br />

to:<br />

1. Apply the WPATH Standards of Care <strong>for</strong> Gender Identity<br />

Disorders.<br />

2. List the surgical options <strong>for</strong> male-to-female transsexual<br />

surgery.<br />

3. Describe the potential complications of transsexual<br />

surgery.<br />

4. Review the surgical techniques to optimize postoperative<br />

sexuality <strong>for</strong> the transsexual patient.<br />

ACGME COMPETENCY<br />

Medical Knowledge<br />

Patient Care<br />

TEST QUESTION:<br />

After participating in this session, <strong>for</strong> patients considering<br />

transsexual surgery I will do the following in my practice:<br />

A. Use the WPATH criteria including evaluation by mental<br />

health professionals.<br />

B. Recommend continuing all estrogen treatment prior to<br />

surgery.<br />

C. Do not recommend regular vaginal dilation as part of<br />

postoperative care.<br />

D. Per<strong>for</strong>m cystoscopy preoperatively and postoperatively<br />

to assess voiding and urinary function.<br />

E. Not applicable to my area of practice.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!